ArticleInvestigational new drugs2019

A novel tetravalent bispecific antibody targeting programmed death 1 and tyrosine-protein kinase Met for treatment of gastric cancer.

Weihua Hou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.